BMS-986165

Phase 2 clinical trial of BMS-986165 in patients with Systemic Lupus Erythematosus (SLE) is now recruiting

April 18, 2019

https://clinicaltrials.gov/ct2/show/NCT03920267?type=Intr&cond=Lupus&phase=012345&lupd_s=04%2F08%2F2019&lupd_d=14

April 18, 2019

https://clinicaltrials.gov/ct2/show/NCT03920267?type=Intr&cond=Lupus&phase=012345&lupd_s=04%2F04%2F2019&lupd_d=14

Condition : Systemic Lupus Erythematosus

Intervention : Drug: BMS-986165

Sponsor : Bristol-Myers Squibb

Recruiting

Long-Term Safety and Efficacy Study of BMS-986165 in Participants With Systemic Lupus Erythematosus

NCT03920267

Thu, 18 Apr 2019 12:00:00 EDT

January 21, 2019

https://clinicaltrials.gov/ct2/show/NCT03252587

An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus